References
- Carlson L. A., Kolmodin-Hedman B. Hyper-α-lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta med. scand. 1972; 192: 29
- Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmac. Rev. 1967; 19: 317
- Coyne M. J., Bonorris G. G., Goldstein L. J., Schoenfield L. J. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gall stones. J. Lab. clin. Med. 1976; 87: 281
- Gordon T. High density lipoproteins and atherosclerosis: comments on epidemiological background. High density lipoproteins and atheroselerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier, North-Holland 1978; 121
- Gordon T., Castelli W. P., Hjortland M. C., Kannel W., Damber T. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am. J. Med. 1977; 62: 707
- Greim H., Schenkman M., Klotzbucher M., Remmer H. The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 in the rat. Biochem. biophys. Acta 1970; 201: 20
- Huang T. C., Chen C. P., Wefler V., Raftery A. A stable reagent for the Liebermann-Burchard reaction, application to rapid serum cholesterol determinations. Analyt. Chem. 1961; 33: 1405
- Ishikawa T. T., Stewart L. E., Brazier J. B., Steiner P. M., Cartside P. S., Glueck C. J. A study of the heparin-manganese chloride method for determination of plasma α-lipoprotein cholesterol concentration. Lipids 1976; 11: 628
- Johansson B. G., Medhus A. Increase in plasma a-lipoproteins in chronic alcoholics after acute abuse. Acta med. scand. 1974; 195: 273
- Jones A. L., Armstrong D. T. Increased cholesterol biosynthesis following phenobarbital induced hypertrophy of agranular endoplasmic reticulum in liver. Proc. Soc. exp. Biol. Med. 1965; 119: 1136
- Livingston S. Phenytoin and serum cholesterol. Br. med. J. 1976; i: 586
- Miller G. J., Miller N. E. Plasma-high-density lipoproteins concentration and development of ischaemic heart disease. Lancet 1975; i: 16
- Miller N. E., Forde O. H., Thelle D. S., Mjøs O. D. The Tromso Heart Study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977; i: 965
- Nikkilä E. A., Kaste M., Enholm C., Viikari J. Increase in serum high density lipoprotein in phenytoin users. Br. med. J. 1978; ii: 99
- Pelkonen R., Fogelholm R., Nikkilä E. A. Increase in serum cholesterol during phenytoin treatment. Br. med. J. 1975; ii: 85
- Reunanen M. I., Sotaniemi E. A. Effect of diphenylhydantoin on serum cholesterol and triglyceride levels in patients with epilepsy. Epilepsy, The Eight International Symposium, J. K. Penry. Raven Press, New York 1977; 215
- Rössner S., Kjellin K. G., Mettinger K. L., Siden Å., Söderström C. E. Normal Serum-cholesterol, but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet 1978; i: 577
- Sotaniemi E. A., Pelkonen R. O., Ahokas J., Pirttiaho H. I., Ahlquist J. Drug metabolism in epileptics. In vivo and in vitro correlations. Br. J. clin. Pharmac. 1978; 5: 71
- Sotaniemi E. A., Pelkonen R. O., Ahokas J. T., Pirttiaho H. I., Ahlquist J. Relationship between in vivo and in vitro drug metabolism in man. Eur. J. Drug Metab. Pharmacokin. 1978; 3: 39
- Wahlefeld A. Q. Triglycerides. Determination after enzymatic hydrolysis. Methods of Enzymatic Analysis, H. U. Bergemeyer. Academic Press Inc., New York and London 1974; 1831
- Wood P. D., Haskell Q., Klein H., Lewis S., Stern M. P., Farquhar J. W. The distribution of plasma lipoprotein in middle-aged male runners. Metabolism 1976; 25: 1249